Literature DB >> 8922496

Intravenous gamma globulin in refractory thrombotic thrombocytopenic purpura.

A Nosari1, G Muti, G Busnach, S Cantoni, A Strinchini, E Morra.   

Abstract

We report the case of a young woman with refractory thrombotic thrombocytopenic purpura (TTP), treated with different therapies (standard therapy with plasma exchange, prostacyclin infusion, vincristine sulfate) and responding to these for brief periods. High-dose immunoglobulin (400 mg/kg/day for 5 days), on the other hand, yielded a complete response which has lasted for 14 months up to the time of this report.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922496     DOI: 10.1159/000203797

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

1.  Intravenous gamma globulin for thrombotic microangiopathy of unknown etiology.

Authors:  Shuichi Ito; Kenichi Okuyama; Tomoko Nakamura; Jun-Ichi Tetanishi; Kazuo Saito; Masanori Matsumoto; Yoshihiro Fujimura; Yukoh Aihara; Shumpei Yokota
Journal:  Pediatr Nephrol       Date:  2006-10-21       Impact factor: 3.714

2.  High-dose immunoglobulin infusion for thrombotic thrombocytopenic purpura refractory to plasma exchange and steroid therapy.

Authors:  Seh Jong Park; Seok Jin Kim; Hee Yun Seo; Moon Ju Jang; Doyeun Oh; Byung Soo Kim; Jun Suk Kim
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 2.884

3.  Postoperative thrombotic thrombocytopenic purpura after aortofemoral bypass.

Authors:  Naba R Mainali; Madan R Aryal; Madan Badal; Vijaya R Bhatt; Richard Alweis
Journal:  J Community Hosp Intern Med Perspect       Date:  2013-01-07

4.  Acquired idiopathic thrombotic thrombocytopenic purpura successfully treated with intravenous immunoglobulin and glucocorticoid: A case report.

Authors:  Hiro Nakao; Akira Ishiguro; Nahoko Ikoma; Kentaro Nishi; Chemin Su; Hisaya Nakadate; Mitsuru Kubota; Masaki Hayakawa; Masanori Matsumoto
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.